The U.S. is getting a third vaccine to prevent COVID-19 after the Food and Drug Administration (FDA) on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85 per cent protective against the most severe COVID-19 illness, in a massive study that spanned three continents.
As Jennifer Johnson reports, the approval follows a rise in COVID-19 cases linked to new variants.
For more info, please go to https://globalnews.ca/news/7667620/johnson-johnson-vaccine-covid-approved/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#coronavirus #COVID19 #GlobalNews
The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85 per cent protective against the most severe COVID-19 illness, in a massive study that spanned three continents.
As Jennifer Johnson reports, the approval follows a rise in COVID-19 cases linked to new variants.
For more info, please go to https://globalnews.ca/news/7667620/johnson-johnson-vaccine-covid-approved/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#coronavirus #COVID19 #GlobalNews
Sign in or sign up to post comments.
Be the first to comment